Stereoselective characterization of the 1,4-dihydropyridine binding site at L-type calcium channels in the resting state and the opened/inactivated state

Journal of Medicinal Chemistry

Volumn 42, Issue 12, 1999, Pages 2204-2211

  Schleifer, Klaus Jürgen ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; AMINO ACID; CALCIUM CHANNEL; GLYCINE; METHIONINE; NIFEDIPINE DERIVATIVE; PHENYLALANINE; THREONINE; TYROSINE;

ARTICLE; DRUG BINDING SITE; DRUG SELECTIVITY; DRUG STRUCTURE; ENANTIOMER; HYDROGEN BOND; MEMBRANE TRANSPORT; PHARMACOPHORE;

BINDING SITES; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; DIHYDROPYRIDINES; ION CHANNEL GATING; MODELS, MOLECULAR; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 0033578079     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm981114c     Document Type: Article

References (38)

1. Jones, S. W. Overview of Voltage-Dependent Calcium Channels. J. Bioenerg. Biomembr. 1998, 30, 299-312.
2. Birnbaumer, L.; Campbell, K. P.; Catterall, W. A.; Harpold, M. M.; Hofmann, F.; Horne, W. A.; Mori, Y.; Schwartz, A.; Snutch, T. P.; Tanabe, T.; et al. The Naming of Voltage-Gated Calcium Channels. Neuron 1994, 13, 505-506.
3. 2+ Channels. Trends Pharmacol. Sci. 1998, 19, 108-115.
4. 1 Subunit. EMBO J. 1991, 10, 45-49.
5. 2+ Channels by Photoaffinity Labeling with Diazipine. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 9203-9207.
6. 3H]Azidopine within the α1 Subunit. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 10769-10773.
7. Kalasz, H.; Watanabe, T.; Yabana, H.; Itagaki, K.; Naito, K.; Nakayama, H.; Schwartz, A.; Vaghi, P. L. Identification of 1,4-Dihydropyridine Binding Domains within the Primary Structure of the α1 Subunit of the Skeletal Muscle L-type Calcium Channel. FEBS Lett. 1993, 331, 177-181.
8. Peterson, B. Z.; Johnson, B. D.; Hockerman, G. H.; Acheson, M.; Scheuer, T.; Catterall, W. A. Analysis of the Dihydropyridine Receptor Site of L-type Calcium Channels by Alanine-scanning Mutegenesis. J. Biol. Chem. 1997, 272, 18752-18758.
9. He, M.; Bodi, I.; Mikala, G.; Schwartz, A. Motif III S5 of L-type Calcium Channels is Involved in the Dihydropyridine Binding Site. A Combined Radioligand Binding and Electrophysiological Study. J. Biol. Chem. 1997, 272, 2629-2633.
10. Peterson, B. Z.; Tanada, T. N.; Catterall, W. A. Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels. J. Biol. Chem. 1996, 277, 5293-5296.
11. 2+ Channel. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 14906-14911.
12. Schuster, A.; Lacinová, L.; Klugbauer, N.; Ito, H.; Birnbaumer, L.; Hofmann, F. The IVS6 Segment of the L-type Calcium Channel is Critical for the Action of Dihydropyridines and Phenylalkylamines. EMBO J. 1996, 15, 2365-2370.
13. Grabner, M.; Wang, Z.; Hering, S.; Striessnig, J.; Glossmann, H. Transfer of 1,4-Dihydropyridine Sensitivity from L-type to Class A (BI) Calcium Channels. Neuron 1996, 16, 207-218.
14. Mitterdorfer, J.; Wang, Z.; Sinnegger, M. J.; Hering, S.; Striessnig, J.; Grabner, M.; Glossmann, H. Two Amino Acid Residues in the IIIS5 Segment of L-type Calcium Channels Differentially Contribute to 1,4-Dihydropyridine Sensitivity. J. Biol. Chem. 1996, 277, 30330-30335.
15. Triggle, D. J.; Rampe, D. 1,4-Dihydropyridine Activators and Antagonists: Structural and Functional Distinctions. Trends Pharmacol. Sci. 1989, 10, 507-511.
16. SYBYL, version 6.2; Tripos Associates, Inc., St. Louis, MO.
17. Zbinden, P. PrGen 1.5.6; Biographies Laboratory: Basel, CH, 1997.
18. Vedani, A.; Huhta, D. W. A New Force Field for Modeling Metalloproteins. J. Am. Chem. Soc. 1990, 112, 4759-4767.
19. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A new General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1986, 107, 3902-3909.
20. Zbinden, P.; Dobler, M.; Folkers, G.; Vedani, A. PrGen: Pseudoreceptor Modeling Using Receptor-mediated Ligand Alignment and Pharmacophore Equilibration. Quant. Struct-Act. Relat. 1998, 17, 122-130.
21. Vedani, A.; Zbinden, P.; Snyder, J. P.; Greenidge, P. A. Pseudoreceptor Modeling: The Construction of Three-Dimensional Receptor Surrogates. J. Am. Chem. Soc. 1995, 117, 4987-4994.
22. Still, W. C.; Tempczyk, A.; Hawley, R. C.; Hendrickson, T. Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics. J. Am. Chem. Soc. 1990, 112, 6127-6129.
23. Searle, M. S.; Williams, D. H. The Cost of Conformational Order: Entropy Changes in Molecular Associations. J. Am. Chem. Soc. 1992, 114, 10690-10697.
24. Zheng, W.; Stoltefuss, J.; Goldmann, S.; Triggle, D. J. Pharmacologic and Radioligand Binding Studies of 1,4-Dihydropyridines in Rat Cardiac and Vascular Preparations: Stereoselectivity and Voltage Dependence of Antagonist and Activator Interactions. Mol. Pharmacol. 1992, 41, 535-541.
25. 3H]Nitrendipine, to Guinea-Pig Ileal Smooth Muscle. J. Pharmacol. Exp. Ther. 1983, 225, 291-309.
26. Coburn, R. A.; Wierzba, M.; Suto, M. J.; Solo, A. J.; Triggle, A. M.; Triggle, D. J. 1,4-Dihydropyridine Antagonist Activities at the Calcium Channel: A Quantitative Structure-Activity Relationship Approach. J. Med. Chem. 1988, 31, 2103-2107.
27. SPARTAN 3.0; Wavefunction, Inc., Irvine, CA.
28. Cambridge Structural Database, Cambridge Crystallographic Data Centre, 12 Union Rd, Cambridge CB2 1EZ, U.K.
29. Schleifer, K.-J. Quantum Chemical Generation of a Nifedipine Pharmacophore Model. Pharm. Pharmacol. Lett. 1995, 5, 162-165.
30. Rovnyak, G. C.; Kimball, S. D.; Beyer, B.; Cucinotta, G.; DiMarco, J. D.; Gougoutas, J.; Hedberg, A.; Malley, M.; McCarthy, J. P.; Zhang, R.; Moreland, S. Calcium Entry Blockers and Activators: Conformational and Structural Determinants of Dihydropyrimidine Calcium Channel Modulators. J. Med. Chem. 1995, 38, 119-129.
31. Adachi, I.; Yamamori, T.; Hiramatsu, Y.; Sakai, K.; Mihara, S.-I.; Kawakami, M.; Masui, M.; Uno, O.; Ueda, M. Studies on Dihydropyridines. III. Synthesis of 4,7-Dihydrothieno[2,3-b]-pyridines with Vasodilator and Antihypertensive Activities. Chem. Pharm. Bull. 1988, 36, 4389-4402.
32. Höltje, H.-D.; Marrer, S. A Molecular Graphics Study on Structure-Action Relationships of Calcium-Antagonistic and Agonistic 1,4-Dihydropyridines. J. Comput.-Aided Mol. Des. 1987, 1, 23-30.
33. Goldmann, S.; Stoltefuss, J. 1,4-Dihydropyridine: Einfluss von Chiralität und Konformation auf die Calcium-antagonistische und -agonistische Wirkung. (1,4-Dihydropyridines: Influence of Chirality and Conformation to the Calcium Antagonistic and Agonistic Effect.) Angew. Chem. 1991, 103, 1587-1605.
34. Mitterdorfer, J.; Wang, Z.; Sinnegger, M. J.; Hering, S.; Striessnig, J.; Grabner, M.; Glossmann, H. Two Amino Acid Residues in the IIIS5 Segment of L-type Calcium Channels Differentially Contribute to 1,4-Dihydropyridine Sensitivity. J. Biol. Chem. 1996, 271, 30330-30335.
35. Peterson, B. Z.; Tanada, T. N.; Catterall, W. A. Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels. J Biol. Chem. 1996, 271, 5293-5296.
36. 1A Subunit. Role of L-type Met1188. J. Biol. Chem. 1997, 272, 27686-27693.
37. Dewar, M. J. S.; Thiel, W. Ground States of Molecules. 39. MNDO Results for Molecules Containing Hydrogen, Carbon, Nitrogen, and Oxygen. J. Am. Chem. Soc. 1977, 99, 4907-4917.
38. + Conduction and Selectivity. Science 1998, 280, 69-77.